ValuEngine downgraded shares of MetLife (NYSE:MET) from a buy rating to a hold rating in a research note published on Friday.
A number of other research firms have also recently issued reports on MET. Zacks Investment Research cut MetLife from a buy rating to a hold rating in a report on Monday, January 22nd. Wells Fargo set a $62.00 target price on MetLife and gave the stock a buy rating in a report on Thursday, December 14th. Deutsche Bank assumed coverage on MetLife in a report on Tuesday, January 2nd. They issued a hold rating and a $55.00 target price for the company. Goldman Sachs reiterated a buy rating on shares of MetLife in a report on Wednesday, January 31st. Finally, Keefe, Bruyette & Woods reiterated a buy rating and issued a $56.00 target price on shares of MetLife in a report on Friday, February 23rd. One analyst has rated the stock with a sell rating, twelve have issued a hold rating and eight have given a buy rating to the company’s stock. The company has a consensus rating of Hold and an average price target of $56.75.
MET opened at $45.27 on Friday. MetLife has a 52-week low of $43.38 and a 52-week high of $55.91. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.15 and a quick ratio of 0.15. The firm has a market cap of $46,928.83, a P/E ratio of 10.06, a price-to-earnings-growth ratio of 0.74 and a beta of 1.24.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. raised its position in shares of MetLife by 17.1% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 72,131 shares of the financial services provider’s stock worth $3,647,000 after acquiring an additional 10,513 shares in the last quarter. Wagner Wealth Management LLC bought a new position in shares of MetLife in the 4th quarter worth $126,000. Xact Kapitalforvaltning AB raised its position in shares of MetLife by 6.0% in the 4th quarter. Xact Kapitalforvaltning AB now owns 161,838 shares of the financial services provider’s stock worth $8,183,000 after acquiring an additional 9,128 shares in the last quarter. Envestnet Asset Management Inc. raised its position in shares of MetLife by 30.3% in the 4th quarter. Envestnet Asset Management Inc. now owns 234,037 shares of the financial services provider’s stock worth $11,834,000 after acquiring an additional 54,367 shares in the last quarter. Finally, CNB Bank bought a new position in shares of MetLife in the 4th quarter worth $338,000. 77.69% of the stock is owned by hedge funds and other institutional investors.
MetLife Company Profile
MetLife, Inc, through its subsidiaries, engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.